Use of Ketamine Prior to Cardiopulmonary Bypass in Children

Completed · Phase 2

Conditions studied: Ventricular Septal Defect

In brief

To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.

Key facts

Study ID

NCT00556361

Run by

Arkansas Children's Hospital Research Institute

People needed

24

Starts

2004-07-01

Expected to finish

2007-11-01

Last updated by the study team

2007-11-12

Who can join

Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• less than one year of age
• undergoing cardiac surgery for repair of ventricular septal defect
• requiring cardiopulmonary bypass
• not requiring retrogrades cerebral perfusion

You may not qualify if…

• Downs Syndrome

Where it is running

• Arkansas Children's Hospital — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.